Evidence map›Paper›PMID 39910679›Full record

ArticleEuropean journal of medical research2025

Therapeutic effect of dihydroartemisinin on Alzheimer's disease model mice with senile macular degeneration.

Gao Han, Gong Xuewu, Zhang Meng, Wang Yuejing, Wang Yuchun, Zhang Keshuang, Yao Hongbo

Abstract read
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gao HanDepartment of Biochemistry and Molecular Biology, School of Medical Technology, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161006, Heilongjiang, China.
Gong XuewuOphthalmology, Second Affiliated Hospital, Qiqihar Medical University, No. 37, Zhonghua West Road, Qiqihar, 161003, Heilongjiang, China.
Zhang MengScientific Research Department, School of Pharmacy, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161003, Heilongjiang, China.
Wang YuejingDepartment of Histology and Embryology, Heilongjiang Provincial Key Laboratory of Food & Medicine Homology and Metabolic Disease Prevention, School of Basic Medical Sciences, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161003, Heilongjiang, China.
Wang YuchunDepartment of Histology and Embryology, Heilongjiang Provincial Key Laboratory of Food & Medicine Homology and Metabolic Disease Prevention, School of Basic Medical Sciences, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161003, Heilongjiang, China.
Zhang KeshuangDepartment of Histology and Embryology, Heilongjiang Provincial Key Laboratory of Food & Medicine Homology and Metabolic Disease Prevention, School of Basic Medical Sciences, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161003, Heilongjiang, China.
Yao HongboDepartment of Histology and Embryology, Heilongjiang Provincial Key Laboratory of Food & Medicine Homology and Metabolic Disease Prevention, School of Basic Medical Sciences, Qiqihar Medical University, 333 Bukui North Street, Jianhua District, Qiqihar, 161003, Heilongjiang, China. hongboyao2016@126.com.

Funding

Natural Science Foundation of Heilongjiang Province of China LH2021H122
6 · The paper itself

Abstract

objectivesThis study focuses on the preventive and therapeutic effects of Dihydroartemisinin (DHA) on Alzheimer's disease (AD) model mice and the effects of DHA and donepezil on amyloid β-protein deposition and autophagy in nerve cells.

methodsSix autophagy related targets were selected for molecular docking with DHA to predict the affinity between DHA and the target. The AD mouse model was established and treated with donepezil and DHA, respectively. Morris water maze was used to detect the spatial learning and memory ability of AD mice. Hematoxylin eosin (he) staining was used to observe the structural changes of cerebral cortical neurons and retina, and transmission electron microscope was used to observe the structural changes of mitochondria and synapses. Immunohistochemistry (IHC) and immunofluorescence staining were used to detect the deposition of amyloid beta protein. Western blot was used to detect the expression of apoptosis and autophagy related proteins in the brain tissue of mice in each group.

resultsThe results of molecular docking showed that the selected active compounds had good binding activity with the target. The binding energy between DHA and Aβ, Bcl-2, ATG5, LC3, Caspase3, LAMP1 is -5.7, -7.0, -5.8, -7.2, -6.9 kcal/mol. The water maze test showed that compared with the wild type (WT) group, the spatial memory ability of AD model group mice (5× FAD) was significantly decreased, and the search time (27.62 ± 6.51 s vs. 282.80 ± 17.15 s) and average path (106.30 ± 29.65 cm vs. 993.20 ± 135.80 cm) were significantly prolonged. The application of donepezil and DHA significantly shortened the exploration time and average path (donepezil: 116.10 ± 10.58 s, 529.40 ± 106.00 cm; DHA: 99.71 ± 14.22 s, 373.30 ± 60.97 cm). The path to find the platform in DHA treatment group was shorter than donepezil treatment group (P < 0.05). HE staining showed that the arrangement of nerve cells in 5× FAD mice was disordered, and IHC showed that amyloid β-protein deposition was obvious. DHA and donepezil could improve the damage of cerebral cortex structure and reduce the deposition of extracellular amyloid β-protein in AD mice. Transmission electron microscopy showed that DHA and donepezil could reduce mitochondrial vacuolation and synaptic edema. The above results showed that DHA treatment effect was better than donepezil. Compared with the conventional feeding group, autophagy and apoptosis related proteins B-cell lymphoma-2 (BCL2) and anti-thymocyte globulin (ATG) were significantly down regulated in the 5× FAD group, and the expressions of BCL2 and ATG were increased after treatment with DHA and donepezil.

conclusionsDHA combined with BCL2 and ATG protein, through promoting autophagy protein, can reduce the damage of cerebral cortex structure in AD mice, reduce the deposition of extracellular β-amyloid protein, and then improve the memory ability of AD model mice. DHA treatment is superior to donepezil monotherapy.

Indexed as

Alzheimer DiseaseArtemisininsAmyloid beta-PeptidesAnimalsAutophagyDisease Models, AnimalHumansMaleMaze LearningMiceMolecular Docking SimulationAmyloid beta-PeptidesArtemisininsartenimolAge-related macular degenerationAlzheimer’s diseaseAmyloid β-protein depositionDihydroartemisinin

Identifiers

PMID39910679
PMCPMC11796114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.